vinpocetine has been researched along with Degenerative Diseases, Central Nervous System in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeyemi, OO; Awogbindin, IO; Ishola, IO; Olajiga, AE; Olubodun-Obadun, TG | 1 |
| Al-Kuraishy, HM; Alexiou, A; Batiha, GE; Elhussieny, O; Papadakis, M; Saad, HM | 1 |
| Medina, AE | 1 |
| Cselényi, Z; Gulyás, B; Halldin, C; Hillert, J; Karrenbauer, VD; Kostulas, K; Savic, I; Shchukin, Y; Takano, A; Vas, A | 1 |
1 review(s) available for vinpocetine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
New insights on the potential effect of vinpocetine in Parkinson's disease: one of the neglected warden and baffling topics.
Topics: Antioxidants; Dopaminergic Neurons; Humans; Neurodegenerative Diseases; Parkinson Disease; Vinca Alkaloids | 2023 |
1 trial(s) available for vinpocetine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients.
Topics: Adult; Anticonvulsants; Antineoplastic Agents; Binding, Competitive; Biomarkers; Brain Mapping; Carbon Radioisotopes; Cerebral Cortex; Female; Gliosis; Humans; Isoquinolines; Ligands; Male; Molecular Structure; Multiple Sclerosis; Nerve Degeneration; Neurodegenerative Diseases; Neuroglia; Positron-Emission Tomography; Predictive Value of Tests; Radioligand Assay; Receptors, GABA-A; Vinca Alkaloids | 2008 |
2 other study(ies) available for vinpocetine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Vinpocetine prevents rotenone-induced Parkinson disease motor and non-motor symptoms through attenuation of oxidative stress, neuroinflammation and α-synuclein expressions in rats.
Topics: alpha-Synuclein; Animals; Disease Models, Animal; Male; Neurodegenerative Diseases; Neuroinflammatory Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone | 2023 |
Vinpocetine as a potent antiinflammatory agent.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Humans; I-kappa B Kinase; Inflammation; Models, Biological; Neurodegenerative Diseases; Neuronal Plasticity; Nootropic Agents; Phosphodiesterase Inhibitors; Vinca Alkaloids | 2010 |